Emmaus Life Sciences Inc (QB) (EMMA)
USOTC
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current EMMA market cap is 902.1k. The company's latest EPS is USD -0.1010 and P/E is -27.43.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 23.17M | 20.61M | 18.39M | 29.6M | 16.65M |
| Operating Income | -2.35M | -8.86M | -8.5M | 1.83M | -1.89M |
| Net Income | 1.1M | -15.95M | -10.63M | -3.73M | -6.45M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 59.28M | 56.73M | 48.23M | 35.18M | 23.6M |
| Total Liabilities | 64.69M | 78.18M | 82.32M | 82.94M | 80.08M |
| Total Equity | -5.42M | -21.45M | -34.09M | -47.76M | -56.48M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.45M | -1.25M | -5.07M | -1.5M | -2.29M |
| Investing | 5.47M | -6.38M | -2.39M | -432k | 2.5M |
| Financing | -2.31M | 7.41M | 7.23M | 2.48M | -1.35M |
| Market Cap | 902.1k |
| Price to Earnings Ratio | -27.43 |
| Price to Sales Ratio | 10.62 |
| Price to Cash Ratio | 127.65 |
| Price to Book Ratio | -3.13 |
| Dividend Yield | - |
| Shares Outstanding | 63.87M |
| Average Volume (1 week) | 9.83k |
| Average Volume (1 Month) | 45.92k |
| 52 Week Change | -85.23% |
| 52 Week High | 0.09565 |
| 52 Week Low | 0.0001 |
| Spread (Intraday) | 0 (22.76%) |
| Company Name | Emmaus Life Sciences Inc (QB) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.emmausmedical.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
